
|
Welcome to the Middle East Cancer Consortium (MECC) Web site.
Established in 1996, the MECC is a unique partnership between the United States and the Ministries of Health of Cyprus, Egypt, Israel, Jordan, the Palestinian Authority, and Turkey.
This Web site contains information about:
- The origins and governance of the Consortium
- Cancer incidence in the region
- The status of cancer registration in the
Middle East
- Ongoing collaborative cancer research
projects
- Opportunities for funding through small
grants
- Cancer communication activities
- Cancer control activities
Calling attention to:
-
ONS/MECC Symptom Management for Oncology Nurses, June 3-5, 2008, Larnaca, Cyprus
- Workshop on Psycho-Oncology: The role and involvement of the patient's family, Larnaca, Cyprus, May 30 - June 1, 2008
-
MECC PC Monograph: Palliative care in the region represented by the Middle East Cancer Consortium (March 2008)
-
Dr. Joe Harford, Director of NCI’s Office of International Affairs, Recognized
for Decade of Work in the Middle East
- A booklet commemorating the 10th Anniversary of MECC (1996 - 2006)
- MECC Monograph: Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan)
of the Middle East Cancer Consortium (MECC) Compared with US SEER. March 2006. The May 23, 2006 issue of the
NCI Cancer Bulletin includes
a commentary on this monograph by Laurence S. Freedman, Chairman of the MECC Cancer Registry Project Steering Committee.
The commentary is also available here.
- MECC News and Events
|